Citi Appointed Depositary Bank for AnPac Bio-Medical Science Co., Ltd.’s Sponsored ADR Program
February 06 2020 - 10:00AM
Business Wire
Citi’s Issuer Services, acting through Citibank, N.A., has been
appointed by AnPac Bio-Medical Science Co., Ltd. (“Anpac Bio”) as
the depositary bank for its American Depositary Receipt (ADR)
program. Anpac Bio is a leading biotechnology company with
operations in China and the United States focused on early cancer
screening and detection.
Anpac Bio’s program was established in connection with an
approximately $16 million initial public offering of its ADRs
(exclusive of the over-allotment option), priced at $12.00 per ADR.
The ADRs are listed on the NASDAQ Global Market under the symbol
“ANPC”. Each ADR represents one Class A ordinary share of Anpac
Bio. As a single-listed ADR program, the underlying ordinary shares
are not listed or publicly traded in the issuer’s home market.
“Citi’s selection as depositary bank for Anpac Bio’s ADR program
underscores the depth and breadth of our cross-border
capabilities,” said Dirk Jones, Head of Global Issuer Services at
Citi. “Citi is committed to providing Anpac Bio and its investors
with the highest quality ADR services.”
Citi is a leading provider of depositary receipt services. With
depositary receipt programs in 61 markets, spanning equity and
fixed-income products, Citi leverages its global network to provide
cross-border capital market access to issuers, intermediaries and
investors.
For more information about Citi’s Depositary Receipt Services,
please visit www.citi.com/dr.
Citi
Citi, the leading global bank, has approximately 200 million
customer accounts and does business in more than 160 countries and
jurisdictions. Citi provides consumers, corporations, governments
and institutions with a broad range of financial products and
services, including consumer banking and credit, corporate and
investment banking, securities brokerage, transaction services, and
wealth management.
Additional information may be found at www.citigroup.com |
Twitter: @Citi | YouTube: www.youtube.com/citi | Blog:
http://blog.citigroup.com | Facebook: www.facebook.com/citi |
LinkedIn: www.linkedin.com/company/citi
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200206005035/en/
Media: Sophia Anthony Citi Global Public Affairs Banking,
Capital Markets & Advisory Communications +1 (212) 816-7140
sophia.anthony@citi.com
Citigroup (NYSE:C)
Historical Stock Chart
From Mar 2024 to Apr 2024
Citigroup (NYSE:C)
Historical Stock Chart
From Apr 2023 to Apr 2024